[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @RNAiAnalyst Dirk Haussecker Dirk Haussecker posts on X about $srpt, $alny, $arwr, $prme the most. They currently have XXXXXX followers and 1466 posts still getting attention that total XXXXXX engagements in the last XX hours. ### Engagements: XXXXXX [#](/creator/twitter::409194010/interactions)  - X Week XXXXXX -XX% - X Month XXXXXXX +283% - X Months XXXXXXX -XX% - X Year XXXXXXXXX -XX% ### Mentions: XX [#](/creator/twitter::409194010/posts_active)  - X Month XX +154% - X Months XXX -XX% - X Year XXX -XXXX% ### Followers: XXXXXX [#](/creator/twitter::409194010/followers)  - X Week XXXXXX +0.30% - X Month XXXXXX +1.90% - X Months XXXXXX +3.10% - X Year XXXXXX +8.20% ### CreatorRank: XXXXXXX [#](/creator/twitter::409194010/influencer_rank)  ### Social Influence [#](/creator/twitter::409194010/influence) --- **Social category influence** [stocks](/list/stocks) #3765 [finance](/list/finance) [cryptocurrencies](/list/cryptocurrencies) **Social topic influence** [$srpt](/topic/$srpt) #2, [$alny](/topic/$alny) #1, [$arwr](/topic/$arwr) #2, [$prme](/topic/$prme), [$apge](/topic/$apge), [$lly](/topic/$lly), [$ntla2001](/topic/$ntla2001), [$verv](/topic/$verv), [$kalv](/topic/$kalv), [market cap](/topic/market-cap) **Top assets mentioned** [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Alnylam Pharmaceuticals, Inc. (ALNY)](/topic/$alny) [Arrowhead Research Corporation (ARWR)](/topic/$arwr) [Apogee Therapeutics, Inc. Common Stock (APGE)](/topic/$apge) [Eli Lilly and Company (LLY)](/topic/$lly) [Intellia Therapeutics, Inc (NTLA)](/topic/$ntla) [BridgeBio Pharma, Inc. Common Stock (BBIO)](/topic/$bbio) [Dyne Therapeutics, Inc. Common Stock (DYN)](/topic/$dyn) [Avidity Biosciences, Inc. Common Stock (RNA)](/topic/$rna) [Viking Therapeutics, Inc (VKTX)](/topic/$vktx) [Merck & Co., Inc. (MRK)](/topic/$mrk) [Pfizer, Inc. (PFE)](/topic/$pfe) [BEAM (BEAM)](/topic/$beam) [Biogen Inc (BIIB)](/topic/$biib) [SuperRare (RARE)](/topic/$rare) [Novartis AG (NVS)](/topic/$nvs) [Ionis Pharmaceuticals, Inc. Common Stock (IONS)](/topic/$ions) [Amgen, Inc. (AMGN)](/topic/$amgn) ### Top Social Posts [#](/creator/twitter::409194010/posts) --- Top posts by engagements in the last XX hours "@GeneInvesting 'good day for gene therapy'.seriously $SRPT just dropped their gene therapy pipeline except for X LGMD type cause of PRV. :)"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1945845469285880050) 2025-07-17 13:58:06 UTC 19.5K followers, XXX engagements "Really interesting question where $NTLA-2001 will fall in this step-edit dynamics for ATTR-CM. For genome editing in ATTR-CM the earlier the more cost effective. By that logic $NTLA-2001 used first then $BBIO/Pfizer.nobody would pay for 2nd knockdown agent"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1942337968103940439) 2025-07-07 21:40:33 UTC 19.5K followers, 6307 engagements "$ARWR bought some after-hours for giggles. $SRPT"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1945579848560218124) 2025-07-16 20:22:37 UTC 19.5K followers, 2919 engagements "$SRPT does restructuring largely take bankruptcy risk off table.assuming no more Elevidys safety surprises + exon skippers staying on market"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1945749107621961976) 2025-07-17 07:35:12 UTC 19.5K followers, 2228 engagements "$DYN FDA is right to ask for functional (vHOT) endpoint instead of abstract splicing index for AA in DM1. It's good for everybody really. $PEPG $RNA"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1934948230745202794) 2025-06-17 12:16:22 UTC 19.5K followers, 2916 engagements "$VERV $X CVR for starting p3 ASCVD trial currently priced at $XXXX almost as if $LLY=Big Pharma only acquired VERVE-102 to retire yet another 'gene therapy' so it won't compete with conventional drugs. $PFE $SGMO"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1944679151429910692) 2025-07-14 08:43:34 UTC 19.5K followers, 5039 engagements "I like that. While $beam has prime views of Boston and Charles River from the terraces of their glass palace $prme employees get to see their benches during lunch :)"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1945911746549498014) 2025-07-17 18:21:28 UTC 19.5K followers, 1661 engagements "Small dosing adjustments to #Alzheimer's antibody reduced ARIA adverse event from XX% -- XX% at week XX from 25%-- XX% at week XX. .while plaque removal remains 'similar'. $LLY $BIIB"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1942914682471194785) 2025-07-09 11:52:12 UTC 19.5K followers, 2901 engagements "A XX minute heads-up. Sounds serious. $SRPT"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1945576893601706426) 2025-07-16 20:10:53 UTC 19.5K followers, 4614 engagements "$KALV 50k on-demand treatments per year.pill option should grow usage say 60k EKTERLY stands out: oral rapid response clean safety -- only insurance will limit market share XX% market share-- $600M rev MC: $760M well financed Expect solid profits in '26 PT: $25"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1942627017259635175) 2025-07-08 16:49:07 UTC 19.5K followers, 2432 engagements "#biotech Would keep some powder dry. It's obvious that Trump admin wants to let this escalate on August X (=Liberation Day 2) but it will be TACO again a few days thereafter. TACO was essential foe my XXX% gain in X months"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1944306796174217466) 2025-07-13 08:03:58 UTC 19.4K followers, 4010 engagements "On the X hand #FDA said it wants to promote #wearables enabling people access to their health infođź‘Ź. On the other hand it is now threatening to take action against a blood pressure wearable maker for not having it licensed as a medical device. wtf"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1945747758729642252) 2025-07-17 07:29:50 UTC 19.5K followers, 1772 engagements "$PRME $EDIT $SANA.3 #CRISPR names up XXX% on strong volume + in short order none of them have raised"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1942683220497346864) 2025-07-08 20:32:27 UTC 19.5K followers, 11.8K engagements "$apge: ' we are accelerating development plan by running another higher dose trial'. Mmh yep 'accelerating' by taking another year before arriving at p3 dose"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1942195426494435471) 2025-07-07 12:14:08 UTC 19.5K followers, 4217 engagements "Get ready for some volatility as Trump gets ready to fire #Fed chair Powell. Ultimately would be very positive for #biotech. Could be a great buying op"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1945512936191021521) 2025-07-16 15:56:44 UTC 19.5K followers, 2073 engagements "I never considered $MREO because I didn't like their AATD program but $470M market cap and $60M in cash.what am I missing $RARE"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1943049441805766901) 2025-07-09 20:47:41 UTC 19.5K followers, 5875 engagements "@GeneInvesting especially the impressive subQ data for CNS. platform. $srpt $arwr"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1945809743668252910) 2025-07-17 11:36:08 UTC 19.5K followers, XXX engagements "$SRPT impressive results for SUBQ delivery to CNS. Is this huntington's candidate targeting exon X $QURE $ALNY"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1945590783299457446) 2025-07-16 21:06:04 UTC 19.5K followers, 17.5K engagements "Hormone Replacement Therapy.one of @drmakaryFDA's favorite health interventions. Any playable stocks in that regard"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1944867556470481038) 2025-07-14 21:12:14 UTC 19.5K followers, 5053 engagements "$srpt been traveling but aren't they due to report limb girdle data Too busy with salvaging Elevidys and keeping company liquid"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1940722085208486363) 2025-07-03 10:39:36 UTC 19.5K followers, 3484 engagements "$ALNY treading water in this biotech bull tape as they watch valuation of $PRME quadruple in short order. What a generational missed opportunity to fortify their franchises. Still there is $NTLA for them but I'm just a tweeter on X"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1942960763590599039) 2025-07-09 14:55:19 UTC 19.5K followers, 3621 engagements "$lly RNAi drug. 2029 primary completion. $nvs $ions and $amgn $arwr next year read-out. Lpa"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1943607302998597953) 2025-07-11 09:44:26 UTC 19.5K followers, 6334 engagements "@deusexdividend X years $VERV was about to start p2 in 2025. Phase 3s should then start in 2027. So likely X 1/2 years if safety deemed approriate for ASCVD population. $LLY"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1944862132668895631) 2025-07-14 20:50:40 UTC 19.5K followers, XXX engagements "$PRME has become a cult stock because the potential is limitless and they are far ahead of the prime editing game including IP"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1942258102406873480) 2025-07-07 16:23:11 UTC 19.4K followers, 17K engagements "I won't tire saying it but with $ALNY MC42x $NTLA MC and $NTLA-2001 not yet commercial (antitrust) they still have an opportunity to go after $NTLA"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1942338563875770722) 2025-07-07 21:42:55 UTC 19.5K followers, 2413 engagements "$apge priced for perfection or near that with $2.8B market cap on eve of critical atopic derm read-out. Science risk seems low but then again why are they first in category Also pin action on $nktr of interest"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1942104658488565894) 2025-07-07 06:13:27 UTC 19.5K followers, 4978 engagements "HYPE XXX crypto -- +300% in pre-market. Drug development is hard fleecing people with crypto.easy. $SONN"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1944706566860439969) 2025-07-14 10:32:31 UTC 19.5K followers, 8698 engagements "$srpt been out all day but -X% suggests it's kneejerk to $capr CRL and #FDA not believing in medicines for DMD"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1943728660491460659) 2025-07-11 17:46:40 UTC 19.5K followers, 4079 engagements "$APGE clearly efficacious though pbo response on high end. On safety XX% non-infective #conjunctivitis taking median of XX days to resolve. I'll trade that in for an ISR any day -- $NKTR"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1942175248159219733) 2025-07-07 10:53:57 UTC 19.5K followers, 16.7K engagements "@Sanctuary_Bio Thanks for that I owe you. $SRPT"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1945580253021147214) 2025-07-16 20:24:14 UTC 19.5K followers, 1103 engagements "$KALV oral on-demand pill for HAE approved by FDA $APGE anti-IL13 p2 hits in atopic dermatitis $JSPR CS Urticaria drug efficacious but manufacturing issues Quite the morning in the #dermatology space"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1942209228522856750) 2025-07-07 13:08:59 UTC 19.5K followers, 5632 engagements "Analysts on the $SRPT call right now: please ask this question. If it targets exon X it could be a tremendously valuable program esp if upcoming $QURE 3-year data positive. Would likely leap-frog $ALNY's program too. $ARWR"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1945593959566188597) 2025-07-16 21:18:42 UTC 19.5K followers, 9785 engagements "@wkissel @BowTiedBiotech @aasgardinvest I believe for non-immunostimulatory #RNAi agents in #HBV time to shift focus from 'functional cure' to outcomes study following chronic semiannual treatment. $ARWR"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1942179396934062296) 2025-07-07 11:10:26 UTC 19.4K followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@RNAiAnalyst Dirk Haussecker
Dirk Haussecker posts on X about $srpt, $alny, $arwr, $prme the most. They currently have XXXXXX followers and 1466 posts still getting attention that total XXXXXX engagements in the last XX hours.
Engagements: XXXXXX #
- X Week XXXXXX -XX%
- X Month XXXXXXX +283%
- X Months XXXXXXX -XX%
- X Year XXXXXXXXX -XX%
Mentions: XX #
- X Month XX +154%
- X Months XXX -XX%
- X Year XXX -XXXX%
Followers: XXXXXX #
- X Week XXXXXX +0.30%
- X Month XXXXXX +1.90%
- X Months XXXXXX +3.10%
- X Year XXXXXX +8.20%
CreatorRank: XXXXXXX #
Social Influence #
Social category influence stocks #3765 finance cryptocurrencies
Social topic influence $srpt #2, $alny #1, $arwr #2, $prme, $apge, $lly, $ntla2001, $verv, $kalv, market cap
Top assets mentioned Sarepta Therapeutics, Inc. (SRPT) Alnylam Pharmaceuticals, Inc. (ALNY) Arrowhead Research Corporation (ARWR) Apogee Therapeutics, Inc. Common Stock (APGE) Eli Lilly and Company (LLY) Intellia Therapeutics, Inc (NTLA) BridgeBio Pharma, Inc. Common Stock (BBIO) Dyne Therapeutics, Inc. Common Stock (DYN) Avidity Biosciences, Inc. Common Stock (RNA) Viking Therapeutics, Inc (VKTX) Merck & Co., Inc. (MRK) Pfizer, Inc. (PFE) BEAM (BEAM) Biogen Inc (BIIB) SuperRare (RARE) Novartis AG (NVS) Ionis Pharmaceuticals, Inc. Common Stock (IONS) Amgen, Inc. (AMGN)
Top Social Posts #
Top posts by engagements in the last XX hours
"@GeneInvesting 'good day for gene therapy'.seriously $SRPT just dropped their gene therapy pipeline except for X LGMD type cause of PRV. :)"
@RNAiAnalyst on X 2025-07-17 13:58:06 UTC 19.5K followers, XXX engagements
"Really interesting question where $NTLA-2001 will fall in this step-edit dynamics for ATTR-CM. For genome editing in ATTR-CM the earlier the more cost effective. By that logic $NTLA-2001 used first then $BBIO/Pfizer.nobody would pay for 2nd knockdown agent" @RNAiAnalyst on X 2025-07-07 21:40:33 UTC 19.5K followers, 6307 engagements
"$ARWR bought some after-hours for giggles. $SRPT" @RNAiAnalyst on X 2025-07-16 20:22:37 UTC 19.5K followers, 2919 engagements
"$SRPT does restructuring largely take bankruptcy risk off table.assuming no more Elevidys safety surprises + exon skippers staying on market" @RNAiAnalyst on X 2025-07-17 07:35:12 UTC 19.5K followers, 2228 engagements
"$DYN FDA is right to ask for functional (vHOT) endpoint instead of abstract splicing index for AA in DM1. It's good for everybody really. $PEPG $RNA" @RNAiAnalyst on X 2025-06-17 12:16:22 UTC 19.5K followers, 2916 engagements
"$VERV $X CVR for starting p3 ASCVD trial currently priced at $XXXX almost as if $LLY=Big Pharma only acquired VERVE-102 to retire yet another 'gene therapy' so it won't compete with conventional drugs. $PFE $SGMO" @RNAiAnalyst on X 2025-07-14 08:43:34 UTC 19.5K followers, 5039 engagements
"I like that. While $beam has prime views of Boston and Charles River from the terraces of their glass palace $prme employees get to see their benches during lunch :)" @RNAiAnalyst on X 2025-07-17 18:21:28 UTC 19.5K followers, 1661 engagements
"Small dosing adjustments to #Alzheimer's antibody reduced ARIA adverse event from XX% -- XX% at week XX from 25%-- XX% at week XX. .while plaque removal remains 'similar'. $LLY $BIIB" @RNAiAnalyst on X 2025-07-09 11:52:12 UTC 19.5K followers, 2901 engagements
"A XX minute heads-up. Sounds serious. $SRPT" @RNAiAnalyst on X 2025-07-16 20:10:53 UTC 19.5K followers, 4614 engagements
"$KALV 50k on-demand treatments per year.pill option should grow usage say 60k EKTERLY stands out: oral rapid response clean safety -- only insurance will limit market share XX% market share-- $600M rev MC: $760M well financed Expect solid profits in '26 PT: $25" @RNAiAnalyst on X 2025-07-08 16:49:07 UTC 19.5K followers, 2432 engagements
"#biotech Would keep some powder dry. It's obvious that Trump admin wants to let this escalate on August X (=Liberation Day 2) but it will be TACO again a few days thereafter. TACO was essential foe my XXX% gain in X months" @RNAiAnalyst on X 2025-07-13 08:03:58 UTC 19.4K followers, 4010 engagements
"On the X hand #FDA said it wants to promote #wearables enabling people access to their health infođź‘Ź. On the other hand it is now threatening to take action against a blood pressure wearable maker for not having it licensed as a medical device. wtf" @RNAiAnalyst on X 2025-07-17 07:29:50 UTC 19.5K followers, 1772 engagements
"$PRME $EDIT $SANA.3 #CRISPR names up XXX% on strong volume + in short order none of them have raised" @RNAiAnalyst on X 2025-07-08 20:32:27 UTC 19.5K followers, 11.8K engagements
"$apge: ' we are accelerating development plan by running another higher dose trial'. Mmh yep 'accelerating' by taking another year before arriving at p3 dose" @RNAiAnalyst on X 2025-07-07 12:14:08 UTC 19.5K followers, 4217 engagements
"Get ready for some volatility as Trump gets ready to fire #Fed chair Powell. Ultimately would be very positive for #biotech. Could be a great buying op" @RNAiAnalyst on X 2025-07-16 15:56:44 UTC 19.5K followers, 2073 engagements
"I never considered $MREO because I didn't like their AATD program but $470M market cap and $60M in cash.what am I missing $RARE" @RNAiAnalyst on X 2025-07-09 20:47:41 UTC 19.5K followers, 5875 engagements
"@GeneInvesting especially the impressive subQ data for CNS. platform. $srpt $arwr" @RNAiAnalyst on X 2025-07-17 11:36:08 UTC 19.5K followers, XXX engagements
"$SRPT impressive results for SUBQ delivery to CNS. Is this huntington's candidate targeting exon X $QURE $ALNY" @RNAiAnalyst on X 2025-07-16 21:06:04 UTC 19.5K followers, 17.5K engagements
"Hormone Replacement Therapy.one of @drmakaryFDA's favorite health interventions. Any playable stocks in that regard" @RNAiAnalyst on X 2025-07-14 21:12:14 UTC 19.5K followers, 5053 engagements
"$srpt been traveling but aren't they due to report limb girdle data Too busy with salvaging Elevidys and keeping company liquid" @RNAiAnalyst on X 2025-07-03 10:39:36 UTC 19.5K followers, 3484 engagements
"$ALNY treading water in this biotech bull tape as they watch valuation of $PRME quadruple in short order. What a generational missed opportunity to fortify their franchises. Still there is $NTLA for them but I'm just a tweeter on X" @RNAiAnalyst on X 2025-07-09 14:55:19 UTC 19.5K followers, 3621 engagements
"$lly RNAi drug. 2029 primary completion. $nvs $ions and $amgn $arwr next year read-out. Lpa" @RNAiAnalyst on X 2025-07-11 09:44:26 UTC 19.5K followers, 6334 engagements
"@deusexdividend X years $VERV was about to start p2 in 2025. Phase 3s should then start in 2027. So likely X 1/2 years if safety deemed approriate for ASCVD population. $LLY" @RNAiAnalyst on X 2025-07-14 20:50:40 UTC 19.5K followers, XXX engagements
"$PRME has become a cult stock because the potential is limitless and they are far ahead of the prime editing game including IP" @RNAiAnalyst on X 2025-07-07 16:23:11 UTC 19.4K followers, 17K engagements
"I won't tire saying it but with $ALNY MC42x $NTLA MC and $NTLA-2001 not yet commercial (antitrust) they still have an opportunity to go after $NTLA" @RNAiAnalyst on X 2025-07-07 21:42:55 UTC 19.5K followers, 2413 engagements
"$apge priced for perfection or near that with $2.8B market cap on eve of critical atopic derm read-out. Science risk seems low but then again why are they first in category Also pin action on $nktr of interest" @RNAiAnalyst on X 2025-07-07 06:13:27 UTC 19.5K followers, 4978 engagements
"HYPE XXX crypto -- +300% in pre-market. Drug development is hard fleecing people with crypto.easy. $SONN" @RNAiAnalyst on X 2025-07-14 10:32:31 UTC 19.5K followers, 8698 engagements
"$srpt been out all day but -X% suggests it's kneejerk to $capr CRL and #FDA not believing in medicines for DMD" @RNAiAnalyst on X 2025-07-11 17:46:40 UTC 19.5K followers, 4079 engagements
"$APGE clearly efficacious though pbo response on high end. On safety XX% non-infective #conjunctivitis taking median of XX days to resolve. I'll trade that in for an ISR any day -- $NKTR" @RNAiAnalyst on X 2025-07-07 10:53:57 UTC 19.5K followers, 16.7K engagements
"@Sanctuary_Bio Thanks for that I owe you. $SRPT" @RNAiAnalyst on X 2025-07-16 20:24:14 UTC 19.5K followers, 1103 engagements
"$KALV oral on-demand pill for HAE approved by FDA $APGE anti-IL13 p2 hits in atopic dermatitis $JSPR CS Urticaria drug efficacious but manufacturing issues Quite the morning in the #dermatology space" @RNAiAnalyst on X 2025-07-07 13:08:59 UTC 19.5K followers, 5632 engagements
"Analysts on the $SRPT call right now: please ask this question. If it targets exon X it could be a tremendously valuable program esp if upcoming $QURE 3-year data positive. Would likely leap-frog $ALNY's program too. $ARWR" @RNAiAnalyst on X 2025-07-16 21:18:42 UTC 19.5K followers, 9785 engagements
"@wkissel @BowTiedBiotech @aasgardinvest I believe for non-immunostimulatory #RNAi agents in #HBV time to shift focus from 'functional cure' to outcomes study following chronic semiannual treatment. $ARWR" @RNAiAnalyst on X 2025-07-07 11:10:26 UTC 19.4K followers, XXX engagements